An Update on the Medical Management of Prostate Cancer – MM1601
Over the past decade many advances have been made in the medical management of prostate cancer. Various treatment options are now available to patients, nearly all of which have distinct mechanisms of action that can improve survival in those with progressive metastatic prostate cancer.
Modern Medicine – January 2016
Novel Treatment for Unresectable Metastatic Melanoma – MM1502
South Africa, according to the South African Melanoma Advisory Board, has one of the highest incidences of melanoma cancers in the world. While melanoma is the most deadly form of skin cancer, a greater insight into the immune system has led to the launch of the immune checkpoint inhibitor, ipilimumab, for the treatment of advanced (unresectable or metastatic) melanoma.
Modern Medicine – February 2015
Early Breast Cancer New Developments in Diagnosis and Treatment – MM1405
Early (curable) breast cancer is the focus of this article discussing important advances in the diagnosis and treatment of breast cancer. Other articles will cover locally advanced and metastatic breast cancer, updated diagnostic tools, psychosocial care and risk factor modification.
Modern Medicine – May 2014
Breast Cancer Screening, Prevention, Support and Other Aspects – MM1404
An increase in breast cancer survival probably reflects the detection of earlier stage cancers through screening and the wider use of adjuvant systemic therapy.
Modern Medicine – April 2014
A substantial proportion of patients with nonsmall cell lung cancer (NSCLC) present with locally advanced (ie, stage III) disease. Incidence has been divided between stage IIIA and stage IIIB, with additional, and perhaps more practical,
division was between ‘operable’ and ‘inoperable’ patients.
Modern Medicine – April 2014
Radiation Oncology of Lung Cancer: Where Do We Stand? – MM1401
Lung cancer continues to be the major cancer killer in both sexes world-wide. Approximately 1.6 million new cases of lung cancer are diagnosed each year. The overall cure rate from lung cancer is modest (approximately 17%) because majority of patients present with advanced stage at diagnosis. This is irrespective of refinements in histological aspects, better diagnostic and staging tools, including the massive influence of positron emission tomography (PET)
scanning, as well as a sharp shift towards molecular oncology already finding its way into clinical practice. Although there are many treatment modalities employed in lung cancer, radiation therapy (RT) is used in the majority of these, both for cure and palliation.
Modern Medicine – January 2014
Diagnosis and Treatment of Lung Cancer – A Focus on the GPs Role – MM1302
The lung cancer epidemic has mirrored changes in smoking patterns
in many countries and has caused innumerable deaths. Approaches
to identification, diagnosis and treatment of the disease are changing
and are discussed in this article.
Modern Medicine – February 2013
